- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
- Video and telephone consultations
Consultant Haematologist at University College Hospital in London and Honorary Senior Clinical Lecturer at UCL
Area of special interest : Red Cell Disorders, which include haemoglobinopathies and rare anaemias polycythaemias, iron deficiency and iron overload disorders.
Graduated from the University of Giessen in Germany in 2000 . Awarded the MRCP by the Royal College of Physicians in 2008 and the FRCPath from the Royal College of Pathologists in 2013.
Completed haematology training as a specialist Registrar at Bartshealth NHS trust and gained a lot of experience in the broad spectrum of malignant and non-malignant haematology, including laboratory diagnostics. I worked at UCLH/UCL for 2 and a half years (2004-2007) , studying the effect and tolerability of different iron chelators in adult and paediatric patients with haemoglobinopathies and other rare transfusion dependent anaemias and transfusional iron overload
Serves as scientific adviser for Thalassaemia International Federation.
Undergraduate and postgraduate teaching responsibilities.
Principal and Co-investigator in numerous clinical trials in the field of sickle cell disease, thalassaemia and other rare anaemias.
Areas of interest
My area of special interest is Red Cell Disorders, which include haemoglobinopathies ( thalassaemia, sickle cell disease) and rare anaemias but also polycythaemias and iron overload disorders. I treat patients with iron deficiencies or general haematology problems ( i.e., abnormal blood counts, )
Current NHS consultant posts held
Consultant haematologist at UCLH
special research interest in different iron chelators and their effect on the myocardial iron removal. Presented data as posters and oral presentations at various international conferences.
Extensive experience in clinical trials.Currently responsible for Red cell clinical trial clinics at UCLH, investigating new anti-sickling agents, iron chelators, agents which increase the haemoglobin in thalassaemia.
I serve as scientific adviser of thalassaemia integration federation.
I have extensive experience in formal and informal teaching.
Teaching regularly at UCL and Medical School of Nicosia, Cyprus.
Leading a thalasaemia fellowship program at UCLH.
Tutor and program coordinator of upcoming haemogobinopathy MSc course.
In my spare time i enjoy my family, travelling, theatre and playing the piano.
1) A.G Leventis Foundation Scholarship for young scientists for 3 consecutive years.
2)In 2006 scholarship for young researchers in Haemoglobinopathies by the European School of Genetics.
(Additional) Languages spoken
- Greek, Modern - Native or bilingual
- German - Fluent
1)J Overton, P Eleftheriou, W Sapsford
Recurrent acute lower-limb ischaemia with multiple organ infarctions secondary to acute
Ann Vasc Surg 2012 Nov 28;26(8)
2)M Garbowski, P Eleftheriou, D Pennell, M Tanner, J Porter
Impact of compliance, Ferritin and LIC on long-term trends in myocardial T2* with
In ASH Annual Meeting. Volume 112. San Francisco: Blood; 2008::49-50.
3)J Glanville, P Eleftheriou, J Porter
MRI evidence of cardiac iron accumulation in myelodyspasia and unusual anaemias
Blood. 2006;108 abstract 1553.
4)J Porter, M Tanner,D Pennel , P Eleftheriou
Improved myocardial T2* in transfusion dependent anaemias receiving ICL 670
Blood 2005-ASH conference; Abstract 160
5)Eleftheriou P, Tanner M, Pennel D, Porter J
Myocardial T2* improves significantly with one year of treatment with Deferasirox in
transfusion dependent anaemias.
Abstract 66/10th international Conference on Thalassaemia& Haemoglobinopathies in Dubai
6)Eleftheriou P, Tanner M, Pennel D, Porter J
Response of myocardial T2* to oral Deferasirox for 1 year in 29 patients with transfusion-
dependent anaemias; a subgroup analysis.
7)Eleftheriou P, Leddham D, Eccersley L, Shah F, Davis B, Hall-Craggs M,Porter J Heterogeneity of genetic causation, presentation and treatment response of
extramedullary haematopoietic causes in thalassaemia syndromes
10th international Conference on Thalassaemia & haemoglobinopathies (Dubai),Abs.100
8)Combination of automated red cell exchanges and hydroxycarbamidein sickle cell disease
P Eleftheriou et al
Poster at 9th Sickle cell and thalassaemia conference, London October 2015
- MD University of Giessen Germany 2000
- MRCP Royal college of physicians, London, UK 2008
- FRCPath Royal College of Pathologists, London, UK 2013
Reference number 6045577
Details of entry to specialist register
- General Medical Council , 2015
Affiliations / memberships
Royal college of Physicians
Royal College of Pathologists
- 5th Floor UCH Macmillan Cancer Centre Huntley...
- 08:00 - 12:00
- 020 3447 9456
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Intravenous infusion (as sole procedure) - (1-5)
Ultrasound guided biopsy(ies) - (1-5)
Therapeutic venesection - (1-5)
Follow-up out-patient consultation - remote - (1-5)